Latest Asx News

Energy World Corporation appoints Alan Jowell as Executive Chairman to spearhead its strategic review and project development, while exploring asset sales alongside its flagship Pagbilao LNG and Power Project.

Mineral Commodities Limited has completed the sale of its Skaland Graphite Project in Norway for USD 8.75 million as part of its voluntary administration process. The transaction marks a significant step in the company’s restructuring efforts.

Hubify has provided detailed terms of its $250,000 equity investment in Australian AI firm HubLab, reinforcing its AI-first growth ambitions targeting enterprise and government sectors.

L1 Long Short Fund Limited has updated its dividend notification to include the Dividend Reinvestment Plan price, confirming a fully franked quarterly dividend for shareholders.

Burgundy Diamond Mines’ Canadian subsidiary has expanded its tariff-related loan facility by C$60 million, reinforcing its financial resilience amid ongoing trade tensions.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

BluGlass has embarked on a A$1.25 million development program with a major US defence prime, receiving an initial A$560,000 order to develop cutting-edge visible GaN lasers for aerospace and defence applications.

Caprice Resources has raised $12.74 million in a strongly supported placement to accelerate exploration drilling across its Murchison Gold Projects, positioning the company for a busy period of assay results and new targets.

AXP Energy has successfully raised A$800,000 through a share placement to fund development of its Oklahoma oil project and explore new growth opportunities.

Lodestar Minerals has secured a major drilling contract to advance its Ned’s Creek Gold Project towards a maiden resource estimate in 2026, targeting key prospects with a 10,000-metre program.

Polymetals Resources has begun mining high-grade silver ore at its Endeavor mine, revealing silver grades significantly above expectations and initiating a direct shipping ore trial to capitalise on newfound value.

Island Pharmaceuticals has partnered with the Burnet Institute to explore new antiviral applications for its lead drugs, targeting measles, chikungunya, and Ross River virus. This collaboration leverages existing data and government funding to enhance the company’s clinical pipeline without major capital outlay.